A detailed history of Act Capital Management, LLC transactions in Aravive, Inc. stock. As of the latest transaction made, Act Capital Management, LLC holds 18,777 shares of ARAV stock, worth $0. This represents 0.02% of its overall portfolio holdings.

Number of Shares
18,777
Previous 18,777 -0.0%
Holding current value
$0
Previous $19,000 21.05%
% of portfolio
0.02%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$0.93 - $1.9 $1,187 - $2,426
1,277 Added 7.3%
18,777 $19,000
Q1 2022

May 11, 2022

BUY
$1.85 - $2.75 $13,875 - $20,625
7,500 Added 75.0%
17,500 $34,000
Q4 2021

Feb 03, 2022

SELL
$2.19 - $4.07 $29,565 - $54,945
-13,500 Reduced 57.45%
10,000 $22,000
Q2 2021

Aug 16, 2021

BUY
$4.65 - $6.42 $109,275 - $150,870
23,500 New
23,500 $141,000

Others Institutions Holding ARAV

About Aravive, Inc.


  • Ticker ARAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,518,300
  • Description
  • Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...
More about ARAV
Track This Portfolio

Track Act Capital Management, LLC Portfolio

Follow Act Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.